<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-05T14:40:34Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/38687" metadataPrefix="marc">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/38687</identifier><datestamp>2026-02-03T11:06:42Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37953</setSpec></header><metadata><record xmlns="http://www.loc.gov/MARC21/slim" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
   <leader>00925njm 22002777a 4500</leader>
   <datafield ind2=" " ind1=" " tag="042">
      <subfield code="a">dc</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Flores Gómez, Marta</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">García-Cantero, Noelia</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Pineda-Gomez, Juan Pedro</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Moh-Ahmed, Amel</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Flores-Burgess, Antonio</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Díaz-Cabiale, Zaida</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Millón-Peñuela, Carmelo</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="260">
      <subfield code="c">2025-05-16</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="520">
      <subfield code="a">Alcohol Use Disorder (AUD) is a highly prevalent psychiatric and represents a significant public health challenge. Naltrexone (NTX), a mu-opioid receptor antagonist widely used for AUD treatment, has limited efficacy due to side effects and variability in patient response. Interactions between the full-length GAL molecule and the opioid system have been demonstrated. In our recent studies, we showed that the Galanin (1-15) fragment [GAL(1-15)] decreased alcohol seeking along with alcohol consumption. This study aims to examine the effects of GAL(1-15)+NTX on alcohol-seeking behavior and alcohol consumption, as well as the involvement of the mesolimbic system. In rats, we assessed GAL(1-15)+NTX in reward-seeking and the role of GALR2 using the antagonist M871 in the self-administration test. In addition, GAL(1-15)+NTX effects were studied on voluntary alcohol using the two-bottle choice paradigm. Locomotor activity and stereotyped behaviors, along with dopamine release in the dorsal striatum following alcohol injections, were assessed. Moreover, we have analyzed the transcriptional changes of C-Fos, MOR, POMPC, and dopamine receptors in the ventral tegmental area, nucleus accumbens and the hypothalamus. GAL(1-15)+NTX combination reduced alcohol seeking in self-administration and two-bottle choice consumption, with GALR2 involved in the effect. In addition, GAL(1-15)+NTX attenuated alcohol-induced locomotor activity and stereotyped behaviors linked to reduced dopamine release in the dorsal striatum. Notably, these effects were associated with C-Fos, MOR, and dopamine receptor changes, suggesting that the mesolimbic pathway, including the opioid system, is involved in GAL(1-15)+NTX effects. These results open up the possibility of using GAL(1-15) with NTX as a novel strategy in AUD.</subfield>
   </datafield>
   <datafield ind1="8" ind2=" " tag="024">
      <subfield code="a">Flores-Gómez M, Cantero-García N, Pineda-Gómez JP, Moh-Ahmed A, Flores-Burgess A, Díaz-Cabiale Z, Millón C. Galanin(1-15) and Naltrexone: A novel approach for alcohol use disorder in rats, involving the mesolimbic system. Biomed Pharmacother. 2025 May 16;188:118170. doi: 10.1016/j.biopha.2025.118170</subfield>
   </datafield>
   <datafield ind1="8" ind2=" " tag="024">
      <subfield code="a">https://hdl.handle.net/10630/38687</subfield>
   </datafield>
   <datafield ind1="8" ind2=" " tag="024">
      <subfield code="a">10.1016/j.biopha.2025.118170</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Alcohol - Consumo</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Alcohol - Efectos fisiológicos</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Modelos animales en investigación</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Neuropéptidos</subfield>
   </datafield>
   <datafield tag="653" ind2=" " ind1=" ">
      <subfield code="a">Naltrexona</subfield>
   </datafield>
   <datafield ind2="0" ind1="0" tag="245">
      <subfield code="a">Galanin(1-15) and Naltrexone: A novel approach for alcohol use disorder in rats, involving the mesolimbic system.</subfield>
   </datafield>
</record>
</metadata></record></GetRecord></OAI-PMH>